Rodman

According to a tweet by @markflowchatter, Rodman has initiated coverage of Myrexis (NASDAQ: MYRX) with a price target of $6. This article may include mentions of rumors, chatter, or unconfirmed information. Readers should beware that while unconfirmed information may be correlated with increased...